Meeder Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14
| Closed | -$1.63K | – | 864 |
|
|
2025
Q1 | $1.63K | Buy |
+14
| New | +$1.63K | ﹤0.01% | 878 |
|
|
2024
Q3 | – | Sell |
-47
| Closed | -$3.78K | – | 845 |
|
|
2024
Q2 | $3.78K | Buy |
+47
| New | +$3.78K | ﹤0.01% | 806 |
|
|
2020
Q4 | – | Sell |
-1,504
| Closed | -$108K | – | 1884 |
|
|
2020
Q3 | $108K | Sell |
1,504
-307
| -17% | -$22K | 0.01% | 763 |
|
|
2020
Q2 | $149K | Buy |
1,811
+253
| +16% | +$20.8K | 0.01% | 661 |
|
|
2020
Q1 | $92K | Buy |
1,558
+134
| +9% | +$7.91K | 0.01% | 733 |
|
|
2019
Q4 | $147K | Buy |
1,424
+637
| +81% | +$65.8K | 0.01% | 687 |
|
|
2019
Q3 | $17K | Buy |
+787
| New | +$17K | ﹤0.01% | 1361 |
|
|
2019
Q2 | – | Sell |
-146
| Closed | -$2K | – | 2031 |
|
|
2019
Q1 | $2K | Sell |
146
-2,387
| -94% | -$32.7K | ﹤0.01% | 1538 |
|
|
2018
Q4 | $7K | Sell |
2,533
-1,501
| -37% | -$4.15K | ﹤0.01% | 1327 |
|
|
2018
Q3 | $14K | Buy |
4,034
+2,796
| +226% | +$9.7K | ﹤0.01% | 1092 |
|
|
2018
Q2 | $3.96K | Buy |
1,238
+43
| +4% | +$138 | ﹤0.01% | 1319 |
|
|
2018
Q1 | $3K | Sell |
1,195
-159
| -12% | -$399 | ﹤0.01% | 1314 |
|
|
2017
Q4 | $8K | Buy |
1,354
+519
| +62% | +$3.07K | ﹤0.01% | 1179 |
|
|
2017
Q3 | $5K | Buy |
835
+310
| +59% | +$1.86K | ﹤0.01% | 1255 |
|
|
2017
Q2 | $3K | Hold |
525
| – | – | ﹤0.01% | 1311 |
|
|
2017
Q1 | $2K | Sell |
525
-75
| -13% | -$286 | ﹤0.01% | 1347 |
|
|
2016
Q4 | $4K | Buy |
+600
| New | +$4K | ﹤0.01% | 875 |
|